TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival November 29, 2013
TCL Archive In Brief: NCAB To Hear NCI Staff Plans For Implementing Recommendation On Nutrition & Cancer Task Force October 1, 1982